Cargando…
The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemia
BACKGROUND: During treatment for acute lymphoblastic leukaemia (ALL), children are prone to musculoskeletal deterioration. However, non‐invasive tools to measure muscle mass and intramuscular alterations are limited. In this study we explored the feasibility of muscle ultrasound in children with ALL...
Autores principales: | Verwaaijen, Emma J., van Hulst, Annelienke M., Molinger, Jeroen, Hartman, Annelies, Pieters, Rob, Grootenhuis, Martha A., van den Akker, Erica L.T., van den Heuvel‐Eibrink, Marry M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570095/ https://www.ncbi.nlm.nih.gov/pubmed/37562959 http://dx.doi.org/10.1002/jcsm.13305 |
Ejemplares similares
-
Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study
por: Verwaaijen, Emma Jacobine, et al.
Publicado: (2022) -
Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
por: van Hulst, Annelienke M., et al.
Publicado: (2023) -
Risk factors for steroid‐induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review
por: van Hulst, Annelienke M., et al.
Publicado: (2021) -
Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia
por: Verwaaijen, Emma J., et al.
Publicado: (2023) -
Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design
por: van Hulst, A. M., et al.
Publicado: (2021)